Atlas Venture’s Bruce Booth believes more drugmakers are ready to access public marketsOne of the biotech industry’s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug companies will go public on the stock market.“It will definitely change in 2026. We will see a lot more IPOs, is my prediction, […]
